Appendix 1.
Costs used in the model (£), discounted after year one.
| 1.5% discounting | 3.5% discounting | 6% discounting | |
|---|---|---|---|
| PTNS | |||
| ⩾50% improvement | 4,848.79 | 4,678.38 | 4,487.25 |
| No improvement | 2,846.88 | 2,846.88 | 2,846.88 |
| Discontinued | 618.82 | 618.82 | 618.82 |
| SNS | |||
| Temporary SNS, no adverse events | 1,612.94 | 1,612.94 | 1,612.94 |
| Temporary SNS, adverse events | 2,322.98 | 2,322.98 | 2,322.98 |
| Permanent SNS, no adverse events, ⩾50% improvement | 14,775.38 | 14,704.35 | 14,624.68 |
| Permanent SNS, no adverse events, no improvement | 13,829.37 | 13,829.37 | 13,829.37 |
| Temporary SNS with adverse events + permanent SNS with adverse events, ⩾50% improvement | 19,153.28 | 19,082.25 | 19,002.58 |
| Temporary SNS with adverse events + permanent SNS with adverse events, no improvement | 18,207.27 | 18,207.27 | 18,207.27 |
| Temporary SNS with adverse events + permanent SNS no adverse events, ⩾50% improvement | 15,485.41 | 15,414.38 | 15,334.71 |
| Temporary SNS with adverse events + permanent SNS no adverse events, no improvement | 14,539.41 | 14,539.41 | 14,539.41 |
| Temporary SNS no adverse events + permanent SNS with adverse events, ⩾50% improvement | 18,443.24 | 18,372.21 | 18,292.54 |
| Temporary SNS no adverse events + permanent SNS with adverse events, no improvement | 17,497.23 | 17,497.23 | 17,497.23 |
| PTNS + SNS | |||
| PTNS + temporary SNS, no adverse events | 4,459.82 | 4,459.82 | 4,459.82 |
| PTNS + temporary SNS, adverse events | 5,169.86 | 5,169.86 | 5,169.86 |
| PTNS + permanent SNS, no adverse events, ⩾50% improvement | 17,622.26 | 17,551.23 | 17,471.56 |
| PTNS + permanent SNS, no adverse events, no improvement | 16,676.25 | 16,676.25 | 16,676.25 |
| PTNS + temporary SNS with adverse events + permanent SNS with adverse events, ⩾50% improvement | 22,000.16 | 21,929.13 | 21,849.46 |
| PTNS + temporary SNS with adverse events + permanent SNS with adverse events, no improvement | 21,054.15 | 21,054.15 | 21,054.15 |
| PTNS + temporary SNS with adverse events + permanent SNS no adverse events, ⩾50% improvement | 18,332.29 | 18,261.27 | 18,181.60 |
| PTNS + temporary SNS with adverse events + permanent SNS no adverse events, no improvement | 17,386.29 | 17,386.29 | 17,386.29 |
| PTNS + temporary SNS no adverse events + permanent SNS with adverse events, ⩾50% improvement | 21,290.12 | 21,219.09 | 21,139.42 |
| PTNS + temporary SNS no adverse events + permanent SNS with adverse events, no improvement | 20,344.11 | 20,344.11 | 20,344.11 |